Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination
Joanne C Lin, Reem Kais Jan, Robert R. Kydd, Bruce R. Russell
Drug Testing and Analysis April 28, 2011 DOI: 10.1002/dta.285 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Human participants |
| Interventions | BZP TFMPP |
| Dose | BZP 200 mg, TFMPP 60 mg, combination 100/30 mg |
| Duration | Single dose, assessments before and approximately 120 minutes after |
| Measures | Addiction Center Research Inventory (ARCI), Profile of Mood States (POMS), Visual Analog Scales (VAS) |
| Citations | 70 |
| Key findings | BZP produced significant dexamphetamine-like stimulant effects, including euphoria and drug liking, while TFMPP induced fewer stimulant-like effects and increased anxiety; the combination produced dexamphetamine- and MDMA-like effects. |
Abstract
The use of piperazine derivatives, colloquially named 'party pills', has been escalating in New Zealand and worldwide since their introduction in the 1990s. Benzylpiperazine (BZP) is often used alone, or can be combined with trifluoromethylphenylpiperazine (TFMPP). Taken together as an oral dose, they have been reported to produce effects similar to 3, 4-methylenedioxymethamphetamine (MDMA). While the pharmacokinetic data have recently been published, little research has been conducted on the subjective effects of these piperazines on humans. This paper outlines the subjective effects observed following oral doses of BZP (200 mg) and TFMPP (60 mg) alone, or in combination (100/30 mg) compared to placebo. Participants were asked to comment on the subjective effects of each drug using three subjective rating scales-the Addiction Center Research Inventory (ARCI), the Profile of Mood States (POMS), and the Visual Analog Scales (VAS)-before and approximately 120 min after a single dose. BZP showed significant dexamphetamine-like stimulant effects, inducing euphoria, sociability, and drug liking, whereas TFMPP induced fewer stimulant-like effects and increased anxiety, via its serotonergic effects. The combination of BZP and TFMPP induced similar subjective effects, along with well-characterized dexamphetamine- and MDMA-like effects. These subjective data allow for obvious comparisons to be made between party pill drugs and other commonly known stimulants. However, despite estimates of over 20 million doses sold in New Zealand alone and increasing seizures by the Drug Enforcement Administration in the USA, there are no published cases of dependence worldwide. The long-term effects of regular party pill use are also unknown, and create the potential for future research.
Citations in the library
Cited by 5
- Clinical toxicology of newer recreational drugs Clinical Toxicology October 1, 2011
- Special issue on illicit drugs Drug Testing and Analysis September 1, 2011
- Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis Journal of Psychopharmacology June 18, 2018
- Benzylpiperazine: "A messy drug". Drug and Alcohol Dependence July 1, 2016
- Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study Psychopharmacology March 1, 2016
Cites 4
- Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects Journal of Clinical Psychopharmacology August 1, 2000
- Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology April 2011
- Determining the subjective effects of TFMPP in human males. Psychopharmacology August 2010
- Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence October 1, 2003